|
Match
|
Document |
Document Title |
|
|
8754058 |
Inhibitors of FAM3B gene, inhibitor compositions, inhibiting methods and applications of inhibitors in preparing pharmaceuticals
Inhibitors that can inhibit expression of FAM3B gene to reduce the levels of expression products, or can combine the expression products to reduce the activity of promoting lipid synthesis of... |
|
|
8492534 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Compositions and methods for treatment of prostate and other cancers
Therapeutic agents which target heat shock protein (hsp) 27 in vivo are used to provide treatment to individuals, particularly human individuals, suffering from prostate cancer and other cancers... |
|
|
7351579 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Circovirus sequences associated with piglet weight loss disease (PWD)
The genome sequences and the nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences,... |
|
|
6046032 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
ARF-P19, a novel regulator of the mammalian cell cycle
The INK4A (MTS1, CDKN2) gene encodes a specific inhibitor (InK4a-p16) of the cyclin D-dependent kinases CDK4 and CDK6. InK4a-p16 can block these kinase from phosphorylating the retinoblastoma... |
|
|
6008200 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Immunomodulatory oligonucleotides
Oligonucleotides containing unthylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response in a subject are disclosed. Also disclosed are therapies... |
|
|
5998385 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Antisense oligonucleotide modulation of raf gene expression
Oligonucleotides are provided which are targeted to nucleic acids encoding human c-raf and capable of inhibiting raf expression. The oligonucleotides contain a methoxyethoxy (2'-O--CH2 CH2 OCH3)... |
|
|
5891715 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Adenoviral vectors of canine origin
The present invention resides in use of a recombinant adenovirus of animal origin containing a heterologous DNA sequence for the preparation of a pharmaceutical composition intended for the... |
|
|
5691198 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
p16 expression constructs and their application in cancer therapy
A variety of genetic constructs are disclosed that will find both in vitro and in vivo use in the area of tumor biology and cancer therapy. In particular, expression constructs are provided that... |